These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22617357)

  • 1. Amygdala subregions tied to SSRI and placebo response in patients with social anxiety disorder.
    Faria V; Appel L; Åhs F; Linnman C; Pissiota A; Frans Ö; Bani M; Bettica P; Pich EM; Jacobsson E; Wahlstedt K; Fredrikson M; Furmark T
    Neuropsychopharmacology; 2012 Sep; 37(10):2222-32. PubMed ID: 22617357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amygdala-frontal couplings characterizing SSRI and placebo response in social anxiety disorder.
    Faria V; Ahs F; Appel L; Linnman C; Bani M; Bettica P; Pich EM; Wahlstedt K; Fredrikson M; Furmark T
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1149-57. PubMed ID: 24666527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced serotonin synthesis and regional cerebral blood flow after anxiolytic treatment of social anxiety disorder.
    Frick A; Åhs F; Appel L; Jonasson M; Wahlstedt K; Bani M; Merlo Pich E; Bettica P; Långström B; Lubberink M; Fredrikson M; Furmark T
    Eur Neuropsychopharmacol; 2016 Nov; 26(11):1775-1783. PubMed ID: 27642077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy.
    Furmark T; Tillfors M; Marteinsdottir I; Fischer H; Pissiota A; Långström B; Fredrikson M
    Arch Gen Psychiatry; 2002 May; 59(5):425-33. PubMed ID: 11982446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo.
    Furmark T; Appel L; Michelgård A; Wahlstedt K; Ahs F; Zancan S; Jacobsson E; Flyckt K; Grohp M; Bergström M; Pich EM; Nilsson LG; Bani M; Långström B; Fredrikson M
    Biol Psychiatry; 2005 Jul; 58(2):132-42. PubMed ID: 16038684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder.
    Argyropoulos SV; Hood SD; Adrover M; Bell CJ; Rich AS; Nash JR; Rich NC; Witchel HJ; Nutt DJ
    Biol Psychiatry; 2004 Oct; 56(7):503-9. PubMed ID: 15450786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expectancy effects on serotonin and dopamine transporters during SSRI treatment of social anxiety disorder: a randomized clinical trial.
    Hjorth OR; Frick A; Gingnell M; Hoppe JM; Faria V; Hultberg S; Alaie I; Månsson KNT; Rosén J; Reis M; Wahlstedt K; Jonasson M; Lubberink M; Antoni G; Fredrikson M; Furmark T
    Transl Psychiatry; 2021 Nov; 11(1):559. PubMed ID: 34732695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram.
    Carey PD; Warwick J; Niehaus DJ; van der Linden G; van Heerden BB; Harvey BH; Seedat S; Stein DJ
    BMC Psychiatry; 2004 Oct; 4():30. PubMed ID: 15482603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do You Believe It? Verbal Suggestions Influence the Clinical and Neural Effects of Escitalopram in Social Anxiety Disorder: A Randomized Trial.
    Faria V; Gingnell M; Hoppe JM; Hjorth O; Alaie I; Frick A; Hultberg S; Wahlstedt K; Engman J; Månsson KNT; Carlbring P; Andersson G; Reis M; Larsson EM; Fredrikson M; Furmark T
    EBioMedicine; 2017 Oct; 24():179-188. PubMed ID: 29033138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Neurofunctional Effects of Escitalopram in Pediatric Anxiety: A Double-Blind, Placebo-Controlled Trial.
    Lu L; Mills JA; Li H; Schroeder HK; Mossman SA; Varney ST; Cecil KM; Huang X; Gong Q; Ramsey LB; DelBello MP; Sweeney JA; Strawn JR
    J Am Acad Child Adolesc Psychiatry; 2021 Oct; 60(10):1309-1318. PubMed ID: 33548492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute neurofunctional effects of escitalopram during emotional processing in pediatric anxiety: a double-blind, placebo-controlled trial.
    Lu L; Li H; Baumel WT; Mills JA; Cecil KM; Schroeder HK; Mossman SA; Huang X; Gong Q; Sweeney JA; Strawn JR
    Neuropsychopharmacology; 2022 Apr; 47(5):1081-1087. PubMed ID: 34580419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials.
    Hedges DW; Brown BL; Shwalb DA; Godfrey K; Larcher AM
    J Psychopharmacol; 2007 Jan; 21(1):102-11. PubMed ID: 16714326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amygdaloid regional cerebral blood flow and subjective fear during symptom provocation in anxiety disorders.
    Fredrikson M; Furmark T
    Ann N Y Acad Sci; 2003 Apr; 985():341-7. PubMed ID: 12724169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroimaging, genetic, clinical, and demographic predictors of treatment response in patients with social anxiety disorder.
    Frick A; Engman J; Alaie I; Björkstrand J; Gingnell M; Larsson EM; Eriksson E; Wahlstedt K; Fredrikson M; Furmark T
    J Affect Disord; 2020 Jan; 261():230-237. PubMed ID: 31655378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety.
    Furmark T; Appel L; Henningsson S; Ahs F; Faria V; Linnman C; Pissiota A; Frans O; Bani M; Bettica P; Pich EM; Jacobsson E; Wahlstedt K; Oreland L; Långström B; Eriksson E; Fredrikson M
    J Neurosci; 2008 Dec; 28(49):13066-74. PubMed ID: 19052197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of childhood social anxiety disorder.
    Beidel DC; Ferrell C; Alfano CA; Yeganeh R
    Psychiatr Clin North Am; 2001 Dec; 24(4):831-46. PubMed ID: 11723636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral blood flow in subjects with social phobia during stressful speaking tasks: a PET study.
    Tillfors M; Furmark T; Marteinsdottir I; Fischer H; Pissiota A; Långström B; Fredrikson M
    Am J Psychiatry; 2001 Aug; 158(8):1220-6. PubMed ID: 11481154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].
    Ammar G; Naja WJ; Pelissolo A
    Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurobiology and pharmacotherapy of social phobia].
    Aouizerate B; Martin-Guehl C; Tignol J
    Encephale; 2004; 30(4):301-13. PubMed ID: 15538306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.